Abstract:BACKGROUND: Therapeutic hypothermia is widely used to treat traumatic brain injuries (TBIs). However, determining the best hypothermia therapy strategy remains a challenge. We hypothesized that reducing the metabolic rate, rather than reaching a fixed body temperature, would be an appropriate target because optimizing metabolic conditions especially the brain metabolic environment may enhance neurologic protection. A pilot single-blind randomized controlled trial was designed to test this hypothesis, and a nested metabolomics study was conducted to explore the mechanics thereof.METHODS: Severe TBI patients (Glasgow Coma Scale score, 3-8) were randomly divided into the metabolic-targeted hypothermia treatment (MTHT) group, 50% to 60% rest metabolic ratio as the hypothermia therapy target, and the body temperature-targeted hypothermia treatment (BTHT) control group, hypothermia therapy target of 32 degrees C to 35 degrees C body temperature. Brain and circulatory metabolic pool blood samples were collected at baseline and on days 1, 3, and 7 during the hypothermia treatment, which were selected randomly from a subgroup of MTHT and BTHT groups. The primary outcome was mortality. Using H-1 nuclear magnetic resonance technology, we tracked and located the disturbances of metabolic networks.RESULTS: Eighty-eight severe TBI patients were recruited and analyzed from December 2013 to December 2014, 44 each were assigned in the MTHT and BTHT groups (median age, 42 years; 69.32% men; mean Glasgow Coma Scale score, 6.17 +/- 1.02). The mortality was significantly lower in the MTHT than the BTHT group (15.91% vs. 34.09%; p = 0.049). From these, eight cases of MTHT and six cases from BTHT group were enrolled for metabolomics analysis, which showed a significant difference between the brain and circulatory metabolic patterns in MTHT group on day 7 based on the model parameters and scores plots. Finally, metabolites representing potential neuroprotective monitoring parameters for hypothermia treatment were identified through 1H nuclear magnetic resonance metabolomics.CONCLUSION: MTHT can significantly reduce the mortality of severe TBI patients. Metabolomics research showed that this strategy could effectively improve brain metabolism, suggesting that reducing the metabolic rate to 50% to 60% should be set as the hypothermia therapy target. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.

Thiamine Use is Associated with Better Outcomes for Traumatic Brain Injury Patients

Change in Plasma Microparticle Procoagulant Activity after Traumatic Brain Injury

Thiamine preserves mitochondrial function in a rat model of traumatic brain injury, preventing inactivation of the 2-oxoglutarate dehydrogenase complex

Thiamine May Be Beneficial for Patients With Ventilator-Associated Pneumonia in the Intensive Care Unit: A Retrospective Study Based on the MIMIC-IV Database

Comparing Blood Biomarkers to Clinical Decision Rules to Select Patients Suspected of Traumatic Brain Injury for Head Computed Tomography.

Association of Thiamine Use with Outcomes in Patients with Sepsis and Alcohol Use Disorder: an Analysis of the MIMIC-III Database

Change of Serum Levels of Thioredoxin in Patients with Severe Traumatic Brain Injury.

Medication utilization in traumatic brain injury patients—insights from a population-based matched cohort study

Outcomes of Preinjury Use of Statins in Patients with Traumatic Brain Injury: A Systematic Review and Meta-analysis.

Effect of thiamine supplementation in critically ill patients: A systematic review and meta-analysis

The association between ondansetron use and mortality risk of traumatic brain injury patients: a population-based study

Reduced thiamine is a predictor for cognitive impairment of cerebral infarction

Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols

Clinical Predictors of Prognosis in Patients with Traumatic Brain Injury Combined with Extracranial Trauma

Biochemical and Radiological Factors for Prognostication of Traumatic Brain Injury: An Institutional Experience

Prognostic Value of Serum Procalcitonin Based Model in Moderate to Severe Traumatic Brain Injury Patients

Thiamine as a Metabolic Resuscitator after Out-of-hospital Cardiac Arrest

Optimization of Brain Metabolism Using Metabolic-Targeted Therapeutic Hypothermia Can Reduce Mortality from Traumatic Brain Injury

Association of glycemic variability and prognosis in patients with traumatic brain injury: A retrospective study from the MIMIC-IV database

Mild and Severe Blood Alcohol Concentration Effects on Trauma and Traumatic Brain Injury Outcomes

Association Between Percutaneous Oxygen Saturation and Mortality of Patients with Mild Traumatic Brain Injury at ICU Admission: An Analysis of the MIMIC-III Database